Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study

Critical Care Medicine

Volumn 38, Issue 2, 2010, Pages 419-427

  Devlin, John W ^a   Roberts, Russel J ^a   Fong, Jeffrey J ^b   Skrobik, Yoanna ^c   Riker, Richard R ^d   Hill, Nicholas S ^e   Robbins, Tracey ^d   Garpestad, Erik ^e  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^d MAINE MEDICAL CENTER   (United States)

^e TUFTS MEDICAL CENTER   (United States)

Author keywords

Antipsychotic; Critical care; Delirium; Drug therapy; Haloperidol; Intensive care unit; Outcomes; Quetiapine; Randomized controlled trial; Treatment

Indexed keywords

HALOPERIDOL; PLACEBO; QUETIAPINE;

ADULT; AGED; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DELIRIUM; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MORTALITY; MULTICENTER STUDY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CARE; SOMNOLENCE;

EID: 74949114615     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181b9e302     Document Type: Article

References (57)

1. American Psychiatric Association: Task Force on DSM-IV. DSM-IV sourcebook. 1st ed. Washington, DC, American Psychiatric Press, 1994
2. American Psychiatric Association: Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999; 156(5 suppl)):1-20
3. Girard TD, Pandharipande PP, Ely EW: Delirium in the intensive care unit. Crit Care 2008; 12 (Suppl 3):S3
4. Thomason JW, Shintani A, Peterson JF, et al: Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients. Crit Care 2005; 9:R375-381
5. Ely EW, Gautam S, Margolin R, et al: The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001; 27:1892-1900
6. Ely EW, Shintani A, Truman B, et al: Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004; 291:1753-1762
7. Milbrandt EB, Deppen S, Harrison PL, et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004; 32:955-962
8. Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y: Delirium in an intensive care unit: a study of risk factors. Intensive Care Med 2001; 27:1297-1304
9. Jacobi J, Fraser GL, Coursin DB, et al: Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30:119-141 (Pubitemid 34112188)
10. Freedman NS, Gazendam J, Levan L, Pack AI, Schwab RJ: Abnormal sleep/wake cycles and the effect of environmental noise on sleep disruption in the intensive care unit. Am J Respir Crit Care Med 2001; 163:451-457
11. Walder B, Francioli D, Meyer JJ, Lancon M, Romand JA: Effects of guidelines implementation in a surgical intensive care unit to control nighttime light and noise levels. Crit Care Med 2000; 28:2242-2247
12. Ely EW, Stephens RK, Jackson JC, et al: Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals. Crit Care Med 2004; 32:106-112
13. Seitz DP, Gill SS, van Zyl LT: Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry 2007; 68:11-21
14. Riker RR, Fraser GL, Cox PM: Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med 1994; 22:433-440
15. Breitbart W, Marotta R, Platt MM, et al: A double-blind trial of haloperidol, chlorprom-azine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996; 153:231-237
16. Sharma ND, Rosman HS, Padhi ID, Tisdale JE: Torsades de Pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998; 81:238-240
17. Huyse F, van Schijndel RS: Haloperidol and cardiac arrest. Lancet 1988; 2:568-569
18. Jibson MD, Tandon R: New atypical antipsy-chotic medications. J Psychiatr Res 1998; 32:215-228
19. Seeman P: Atypical antipsychotics: mechanism of action. Can J Psychiatry 2002; 47: 27-38
20. Schwartz TL, Masand PS: The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 2002; 43:171-174
21. Anand HS: Olanzapine in an intensive care unit. Can J Psychiatry 1999; 44:397
22. Sipahimalani A, Sime RM, Massand PS: Treatment of delirium with risperidone. Int J Geriatr Psychopharmacol 1997; 1:24-26
23. Breitbart W, Tremblay A, Gibson C: An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psycho-somatics 2002; 43:175-182
24. Torres R, Mittal D, Kennedy R: Use of quetia-pine in delirium: case reports. Psychosomat-ics 2001; 42:347-349
25. Kim KY, Bader GM, Kotlyar V, Gropper D: Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 2003; 16:29-31
26. Leso L, Schwartz TL: Ziprasidone treatment of delirium. Psychosomatics 2002; 43:61-62
27. Platt MM, Breitbart W, Smith M, Marotta R, Weisman H, Jacobsen PB: Efficacy of neuro-leptics for hypoactive delirium. J Neuropsy-chiatry Clin Neurosci 1994; 6:66-67
28. Skrobik YK, Bergeron N, Dumont M, Gottfried SB: Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004; 30:444-449
29. Maneeton B, Maneeton N, Srisurapanont M: An open-label study of quetiapine for delirium. J Med Assoc Thai 2007; 90:2158-2163.
30. Takeuchi T, Furuta K, Hirasawa T, et al: Perospirone in the treatment of patients with delirium. Psychiatry Clin Neurosci 2007; 61: 67-70
31. Nemeroff CB, Kinkead B, Goldstein J: Quetiapine: preclinical studies, pharmacoki-netics, drug interactions, and dosing. J Clin Psychiatry 2002; 63 (Suppl 13):5-11
32. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y: Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 2001; 27:859-864
33. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23:1638-1652
34. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829
35. Riker RR, Picard JT, Fraser GL: Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1999; 27:1325-1329
36. Devlin JW, Fong JJ, Schumaker G, O'Connor H, Ruthazer R, Garpestad E: Use of a validated delirium assessment tool improves the ability of physicians to identify delirium in medical intensive care unit patients. Crit Care Med 2007; 35:2721-2724
37. Devlin JW, Marquis F, Riker RR, et al: Combined didactic and scenario-based education improves the ability of intensive care unit staff to recognize delirium at the bedside. Crit Care 2008; 12:R19
38. European Agency for the Evaluation of Medicinal Products HMEU, Committee for Proprietary Medicinal Products (CPMP): Points to consider: the assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products. London, EMA Press, 1997
39. Moss AJ: Drugs that prolong the QT interval: Regulatory and QT measurement issues from the United States and European perspectives. Ann Noninvasive Electrocardiol 1999; 4:255-256
40. Simpson GM, Angus JW: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212:11-19
41. Trzepacz PT, Bourne R, Zhang S: Designing clinical trials for the treatment of delirium. J Psychosom Res 2008; 65:299-307
42. MacLaren R, Sullivan PW: Pharmacoeco-nomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients. Pharmacotherapy 2005; 25:1319-1328
43. Kaplan EL: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481
44. Rea RS, Battistone S, Fong JJ, Devlin JW: Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy 2007; 27:588-594
45. Schwartz TL, Masand PS: Treatment of Delirium With Quetiapine. Prim Care Companion J Clin Psychiatry 2000; 2:10-12
46. Skrobik Y: Haloperidol should be used sparingly. Crit Care Med 2002; 30:2613-2614
47. Pisani MA, Murphy TE, Araujo KL, Slattum P, Van Ness PH, Inouye SK: Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population. Crit Care Med 2009; 37:177-183
48. Pandharipande PP, Pun BT, Herr DL, et al: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298: 2644-2653
49. Bourne RS, Tahir TA, Borthwick M, Sampson EL: Drug treatment of delirium: past, present and future. J Psychosom Res 2008; 65:273-282
50. de Rooij SE, Schuurmans MJ, van der Mast RC, Levi M: Clinical subtypes of delirium and their relevance for daily clinical practice: a systematic review. Int J Geriatr Psychiatry 2005; 20:609-615
51. Meagher DJ, Trzepacz PT: Motoric subtypes of delirium. Semin Clin Neuropsychiatry 2000; 5:75-85
52. Pandharipande P, Cotton BA, Shintani A, et al: Motoric subtypes of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med 2007; 33:1726-1731
53. Peterson JF, Pun BT, Dittus RS, et al: Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc 2006; 54:479-484
54. http://www.fda.gov/CDER/DRUG/InfoSheets/HCP/haloperidol.htm. Accessed May 22, 2009
55. Mutlu GM, Mutlu EA, Factor P: GI complications in patients receiving mechanical ventilation. Chest 2001; 119:1222-1241
56. Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294:1934-1943
57. Prakanrattana U, Prapaitrakool S: Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 2007; 35:714-719